G-2L9FEZD7KT
top of page
Search

Long-Term TMS Depression Outcomes: A 2026 Guide

Oct 18
8 min read

Table of Contents

  • Understanding Long-Term TMS Depression Outcomes

  • How TMS Works and What Sustained Improvement Looks Like

  • Response, Remission, and Relapse: Clear Definitions

  • How Long Does TMS Last for Depression

  • Maintenance TMS for Depression: Preventing Symptom Return

  • TMS Relapse Rates and Who Is Most Likely to Sustain Improvement

  • TMS Retreatment for Depression: What Happens If Symptoms Return

  • Frequently Asked Questions

Last Updated: October 12, 2026

Understanding Long-Term TMS Depression Outcomes

Long-term TMS depression outcomes refer to how well patients maintain symptom improvement months and years after completing an acute treatment course of transcranial magnetic stimulation. At Newtown TMS, we focus on understanding not just whether TMS works, but how durable those benefits are and what strategies keep patients well once they've achieved improvement.

The question that matters most to patients is simple: Will this improvement last? That's what separates a temporary fix from a real solution. Understanding the trajectory of long-term TMS depression outcomes helps you make an informed decision about whether this treatment fits your situation and what to expect beyond the initial treatment phase.

Most patients enter TMS treatment desperate for relief from depression that hasn't responded to multiple antidepressants. But relief is only the first step. The real measure of success is sustained improvement, maintaining that progress months and years later without sliding back into depression.

How TMS Works and What Sustained Improvement Looks Like

Transcranial magnetic stimulation works by delivering magnetic pulses to specific brain regions involved in mood regulation, typically the dorsolateral prefrontal cortex (the FDA). These pulses stimulate neural activity in areas that show reduced function in depression. The goal is to restore normal communication patterns and help the brain regulate mood more effectively on its own.

Patient seated in comfortable treatment chair in medical office during TMS procedure, physician monitoring equipment with magnetic coil positioned near patient's head, natural clinical lighting

What sustained improvement looks like varies by person. For some, it means returning to work without the fog and fatigue that made concentration impossible. For others, it's reconnecting with family or activities they'd abandoned.

The mechanism matters less than the outcome. What happens neurologically during TMS is complex, but what matters clinically is whether the brain maintains its improved function after treatment ends. Some patients experience immediate relief during the acute treatment course, while others notice gradual improvement over weeks. This variation is normal and doesn't predict long-term outcomes.

Response, Remission, and Relapse: Clear Definitions

Understanding the terminology around long-term TMS depression outcomes prevents confusion about what success actually means. These terms appear throughout clinical discussions, and they mean specific things.

Response means at least a 50 percent reduction in depressive symptoms compared to baseline. If someone started with severe depression, a 50 percent improvement is significant, they function better, sleep better, and experience less emotional pain. But response isn't remission.

Remission is the goal: minimal or no depressive symptoms. A patient in remission feels substantially normal, not just "better than before." The distinction matters because remission is associated with better long-term outcomes than response alone.

Relapse means symptoms return to near-baseline levels after a period of improvement. Recurrence is similar but technically refers to a new depressive episode that develops after a symptom-free period. Both represent loss of the gains achieved during treatment.

Sustained benefit means maintaining response or remission over time. This is what determines whether TMS truly solved the problem or just provided temporary relief. Durability of response is the practical measure of long-term TMS depression outcomes that matters most to patients deciding whether to pursue treatment.

How Long Does TMS Last for Depression

There is no single number for how long TMS benefits last, because "how long" depends on what you're measuring and who you're measuring. A patient who drops from severe to mild depression is a responder, not a remitter, and those two groups have very different durability curves. Before comparing any timeline, separate the outcome measures.

The four measures that drive every durability statistic

  • Response: at least a 50 percent reduction in symptom severity from baseline on a validated scale such as the PHQ-9 or HAM-D.

  • Remission: symptoms fall into the minimal or absent range, not merely "better than before."

  • Relapse: return of symptoms to near-baseline after improvement, usually within the same episode window.

  • Recurrence: a new depressive episode after a period of wellness.

A study reporting "70 percent maintained benefit at six months" may be counting responders, remitters, or anyone who didn't fully relapse. Those are not interchangeable, and the difference explains why headline durability numbers vary so widely across sources.

Outcomes by follow-up interval

Most long-term data clusters at three checkpoints. The pattern below reflects the general shape of the published literature; individual results vary.

  • 3 months post-acute: The strongest retention. Most patients who responded during the acute course are still classified as responders. Relapse in this window is uncommon but not rare, and it is more likely in patients who never reached remission.

  • 6 months post-acute: The picture splits. A meaningful share of initial responders remain in remission, while others show partial symptom return that may not meet full relapse criteria. This is the interval where maintenance decisions usually get made.

  • 12 months and beyond: Durability depends heavily on what happened in between. Patients who continued medication, therapy, or maintenance TMS hold gains better than those who stopped all treatment. Patients with chronic, highly treatment-resistant depression are more likely to need a repeat course within the first year.

Why study design changes the number you see

  • Randomized controlled trials use fixed protocols, blinded raters, and strict entry criteria. They give the cleanest signal but enroll a narrower patient population than real-world clinics see.

  • Open-label extension studies follow patients after the controlled phase, so everyone knows they're getting active treatment. Durability estimates here tend to run higher than blinded data.

  • Observational and real-world registries capture patients with more comorbidity, more prior medication failures, and more concurrent treatment changes. Their durability numbers are usually lower and more variable, but they may better reflect what a typical patient experiences.

When you read a durability claim, ask three questions: Which outcome measure? Which follow-up interval? Which study design? A number without those three answers is not comparable to another number.

Key Takeaway TMS does not permanently rewire the brain. It shifts brain function into a healthier state, and that state is maintained by whatever support continues afterward. Durability is a function of the treatment plus the maintenance plan, not the acute course alone.

Maintenance TMS for Depression: Preventing Symptom Return

Maintenance TMS is a scheduled continuation of treatment at reduced frequency after the acute course ends. It is not a single protocol. Clinics use several different schedules, and the evidence behind each is not equally strong. Knowing which is which helps you ask better questions.

The main maintenance schedules in use

  • Weekly: One session per week, often starting immediately after the acute course. This is the most common starting point and the schedule most often described in the clinical literature.

  • Biweekly: One session every two weeks, typically used as a step-down after a stable period on weekly treatment.

  • Monthly: One session per month, usually a longer-term taper for patients who have held remission for several months.

  • Tapered or as-needed: Sessions spaced further apart over time, or scheduled only when early warning signs appear. This is the least standardized approach and the hardest to study.

The strongest evidence is for continuation treatment in the weeks and months immediately after the acute course, when relapse risk is highest. Beyond that window, evidence for any specific schedule is thinner.

That means a few things in practice:

  • There is no universally agreed "correct" maintenance schedule.

  • Longer intervals are not automatically better or worse; they are a trade-off between convenience and protection.

  • Some patients do well on monthly sessions; others relapse on the same schedule.

How the schedule gets chosen

Clinicians generally weigh four factors: how severe the depression was before treatment, how complete the remission was, how many prior episodes the patient has had, and what other treatments are in place. A patient in full remission after a first episode may taper quickly.

Maintenance is not indefinite for everyone

Some patients need maintenance for a few months. Others need it for years. The goal is to find the lowest frequency that keeps symptoms controlled, then reassess periodically.

Where concurrent treatment fits

Maintenance TMS is rarely the only thing happening. Antidepressants, psychotherapy, sleep and lifestyle changes, and regular symptom monitoring all interact with TMS durability.

Watch Out Maintenance TMS is not a guarantee against relapse. It lowers risk for many patients, but it does not eliminate it. Anyone considering maintenance should have a written plan for what happens if symptoms return.

TMS Relapse Rates and Who Is Most Likely to Sustain Improvement

Not everyone maintains the same level of improvement. Understanding which patients sustain benefits helps set realistic expectations for long-term TMS depression outcomes.

Patients most likely to sustain improvement share certain characteristics. Those who achieve full remission (not just response) during acute treatment tend to maintain benefits longer. Patients who continue concurrent treatments, medication, therapy, or both, show better durability than those who rely on TMS alone. Individuals with first-episode depression or shorter illness duration often sustain improvement better than those with decades of chronic depression.

Conversely, some patients experience relapse within months. Those with treatment-resistant depression that required multiple failed medication trials may have more fragile remission. Patients with comorbid conditions like anxiety or chronic pain sometimes experience relapse when those conditions aren't adequately addressed. Life stress, medication changes, or discontinuation of psychotherapy can trigger symptom return even in patients who initially responded well.

The honest assessment: relapse happens. But relapse doesn't mean TMS failed. It means the brain needs continued support to maintain the gains. This is why maintenance strategies matter and why understanding long-term TMS depression outcomes includes planning for what happens if symptoms return.

TMS Retreatment for Depression: What Happens If Symptoms Return

If depressive symptoms return after a period of improvement, retreatment is an option. Many patients who relapse respond well to a second or subsequent TMS course, often more quickly than the initial treatment.

The pattern often looks like this: acute treatment brings remission, maintenance therapy keeps symptoms controlled, but life circumstances or other factors lead to relapse. A repeat TMS course, sometimes combined with medication adjustment or intensified therapy, typically restores improvement.

Retreatment outcomes are generally favorable. Patients who responded to initial TMS often respond to repeat courses. The brain appears to "remember" the beneficial effects, and subsequent treatments sometimes work faster than the first course.

This reality shapes how we think about long-term TMS depression outcomes. It's not a one-time fix but a tool that can be used repeatedly as needed. For patients with chronic depression, this represents genuine progress, a non-medication option that works when needed and can be discontinued when symptoms are controlled.

The goal of long-term TMS depression outcomes is sustained function and reduced suffering. Whether that means permanent remission, periodic maintenance, or strategic retreatment depends on your individual situation.

Frequently Asked Questions

How long do the effects of TMS for depression last?

Clinical studies show that TMS benefits can persist for months to years after an acute treatment course ends. Many patients maintain remission or significant symptom reduction for 6-12 months or longer without additional treatment. However, duration varies based on individual factors, concurrent medications, psychotherapy, and whether maintenance TMS is pursued. Long-term outcomes depend on your specific treatment protocol and follow-up care strategy.

What are typical TMS relapse rates for depression?

Relapse rates vary by study design and follow-up period. Research indicates that 15-50% of patients who achieve remission may experience symptom recurrence within 6-12 months without maintenance treatment. Factors affecting relapse include treatment-resistant depression severity, medication status, psychotherapy engagement, and individual brain chemistry. Regular monitoring and proactive maintenance strategies significantly reduce relapse risk.

Is maintenance TMS for depression necessary after initial treatment?

Maintenance TMS is not mandatory but is often recommended, especially for patients with chronic depression or prior relapse history. Evidence supports maintenance treatment to sustain long-term remission and prevent symptom return. Your physician can assess whether maintenance TMS fits your long-term depression management plan based on your response to acute treatment and individual relapse risk factors.

Can you have another course of TMS if depression symptoms return?

Yes, TMS retreatment is an established option if symptoms return after initial treatment. Many patients respond well to repeat courses, with response and remission rates comparable to or sometimes better than the first course. Retreatment timing, frequency, and protocol depend on symptom severity and your physician's assessment. Discuss retreatment eligibility during your consultation.

What factors affect how long TMS benefits last for depression?

Long-term outcomes depend on concurrent antidepressant medications, ongoing psychotherapy, stress management, sleep quality, and individual neurobiological factors. Patients combining TMS with medication and talk therapy often sustain improvement longer than those using TMS alone. Baseline depression severity, treatment-resistant status, and adherence to follow-up care also influence durability of response.

Call Newtown TMS for a free consultation

 
 
 

Comments


Newtown TMS

johnwoodallmd@newtowntms.com

​

(475) 225-5098

153 South Main St., Newtown, CT 06470

  • alt.text.label.Facebook

©2026 by Newtown TMS. Proudly created with Wix.com

bottom of page